Is Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) a Buy, Sell, or Hold?
NASDAQ : DMAA
Drugs Made In America Acquisition Corp. Ordinary Shares — Competitors
$10.71 USD
-$0.01 (-0.05%)
- Volume
- 0.91
- Average Volume
- 36.51K
- Market Capitalization
- $361.11M
- P/E Ratio
- 52.35
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $10.73
- Year Low
- $10.22
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.03
DMAA vs. The Competition
| Properties | DMAA | ALF | LOKV | MLAC |
|---|---|---|---|---|
| Market Cap | $361.11M | $388.48M | $331.2M | $30.37M |
| Shares Outstanding | $33.72M | $35.94M | $28.75M | $30.99M |
| P/E Ratio | 52.35 | 34.2 | -33.5 | 3.72 |
| EPS | 0.29 | 0.31 | -0.45 | 0.34 |
| Day Low | 10.68 | 10.76 | 11.21 | 0.95 |
| Day High | 10.7186 | 10.81 | 11.89 | 1.2196 |
| Year Low | 10.22 | 10.45 | 8.655 | 0.9601 |
| Year High | 10.7295 | 10.99 | 11.99 | 10.69 |
| Average Price 50 | 10.6443 | 10.85332 | 10.47526 | 9.77026 |
| Average Price 200 | 10.48233 | 10.74632 | 10.33995 | 10.26039 |
| Volume | 0.91 | 115 | 68134 | 2.57M |
| Average Volume | - | - | - | - |